Title:
NLRP3 INFLAMMASOME INHIBITORS AND USES THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/094150
Kind Code:
A1
Abstract:
Described herein are NOD-like receptor protein 3 (NLRP3) inflammasome inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of a disease or disorder associated with NLRP3 inflammasome pathway.
More Like This:
Inventors:
LIU YINGTAO (CN)
WU JIANPING (CN)
DING XIAOYU (CN)
QIN LUOHENG (CN)
LI CHAOPENG (CN)
WU JIANPING (CN)
DING XIAOYU (CN)
QIN LUOHENG (CN)
LI CHAOPENG (CN)
Application Number:
PCT/CN2023/129502
Publication Date:
May 10, 2024
Filing Date:
November 03, 2023
Export Citation:
Assignee:
INSILICO MEDICINE IP LTD (CN)
International Classes:
C07D253/07; A61K31/50; A61K31/5025; A61P3/10; A61P19/02; A61P25/16; C07D253/06; C07D253/10; C07D487/04; C07D487/06
Domestic Patent References:
WO2022230912A1 | 2022-11-03 | |||
WO2022166890A1 | 2022-08-11 | |||
WO2022060951A1 | 2022-03-24 |
Foreign References:
CN116102535A | 2023-05-12 | |||
CN116410140A | 2023-07-11 | |||
TW202231281A | 2022-08-16 | |||
CN113784957A | 2021-12-10 | |||
US3873543A | 1975-03-25 | |||
GB1492073A | 1977-11-16 |
Attorney, Agent or Firm:
AFD CHINA INTELLECTUAL PROPERTY LAW OFFICE (CN)
Download PDF: